Explore 3 Stock Ideas & Industry Insights Download Free Report

Utah Medical Products Inc

Company price
71.97 USD -1.66 ( 2.25%)
Last update at 2026-11-13T21:00:00Z
VOLUME
13334
Market Cap
237.61M
P/E
22.75

Momentum Score

…

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
71.83
Low
73.31
High
52 Week Price Range
52.87
Low
75.75
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Utah Medical Products (UTMD) makes specialized airway-management medical devices sold mainly to hospitals and distributors. Long-term growth drivers include aging demographics, steady clinical demand for respiratory care, incremental product upgrades and modest international expansion. Investors may find the company attractive because it operates in a narrow, specialized market with recurring demand and apparent operating scale in its niche.

Material risks include product and customer concentration, regulatory and reimbursement changes, competition from larger device makers and execution or supply-chain disruptions.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
73.63
Dividend Yield
1.75%
Revenue TTM
36.11M
Revenue Per Share
11.31
Gross Profit TTM
20.91M
Debt / Equity
0.00
ROE
8.76%
Net Debt
-85.53M
ROCE
11.76%
Diluted EPS TTM
3.28

Insight Announcement

Utah Medical Products Q3 2026: Net Income $2.79M

Shwetambri Chauhan | 3 days, 9 hours ago
View All

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 14.11M 16.80M 20.09M 20.66M 19.06M
Net income 11.29M 13.87M 16.64M 16.47M 15.18M
Selling general administrative 9.93M 3.67M 11.02M 10.41M 10.10M
Selling and marketing expenses - 1.90M 1.69M 1.51M 1.41M
Gross profit 19.88M 24.14M 30.04M 32.20M 30.92M
Reconciled depreciation 3.01M 2.85M 7.08M 7.08M 7.28M
Ebit 14.11M 16.80M 18.38M 12.71M 18.88M
Ebitda 17.06M 19.57M 24.75M 19.79M 30.92M
Depreciation and amortization 2.95M 2.77M 6.37M 7.08M 12.04M
Non operating income net other - - - 0.21M 0.01M
Operating income 11.40M 13.59M 16.78M 12.71M 18.88M
Other operating expenses 27.12M 27.31M 33.45M 32.49M 18.14M
Interest expense - - - -0.87M 4.18M
Tax provision 2.82M 2.93M 3.76M 4.19M 4.27M
Income tax expense 2.82M 2.93M 3.45M 4.19M 4.27M
Total revenue 38.52M 40.90M 50.22M 52.28M 49.05M
Total operating expenses 8.47M 10.55M 13.26M 12.41M 12.04M
Cost of revenue 18.64M 16.76M 20.19M 20.09M 18.14M
Total other income expense net 2.71M 3.21M 3.31M 7.95M 0.18M
Net income from continuing ops 11.29M 13.87M 16.90M 20.66M 19.06M
Net income applicable to common shares - - - 16.47M 14.79M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 122.54M 122.54M 135.46M 123.87M 115.56M
Intangible assets 0.84M 2.87M 4.95M 10.38M 17.31M
Other current assets 0.53M 0.45M 0.43M 0.52M 0.46M
Total liab 3.27M 5.11M 7.14M 9.62M 8.42M
Total stockholder equity 119.27M 117.43M 128.31M 114.25M 107.14M
Deferred long term liab - - - 0.55M 0.58M
Other current liab 1.69M 3.21M 3.57M 4.54M 2.84M
Common stock 0.03M 0.03M 0.04M 0.04M 0.04M
Capital stock 0.03M 0.03M 0.04M 0.04M 0.04M
Retained earnings 128.65M 129.30M 138.34M 126.01M 115.31M
Other liab - - - 3.32M 4.49M
Good will 14.05M 13.58M 13.69M 13.35M 14.10M
Other assets - - 0.00M - -0.00M
Cash 85.76M 82.98M 92.87M 75.05M 60.97M
Total current liabilities 2.60M 3.76M 4.71M 5.75M 3.60M
Current deferred revenue - - 0.33M - -
Net debt -85.53M -82.69M -92.53M -74.71M -60.64M
Short term debt - - 0.05M - -
Short long term debt total 0.23M 0.28M 0.34M 0.34M 0.33M
Other stockholder equity 119.27M -11.91M 0.59M 0.25M 0.84M
Property plant equipment - - - 10.22M 10.99M
Total current assets 97.74M 96.33M 106.27M 89.92M 73.16M
Net tangible assets - - - 90.52M 75.73M
Short term investments - - 185.74M - -
Net receivables 3.52M 4.09M 3.39M 5.54M 5.13M
Inventory 7.93M 8.81M 9.58M 8.81M 6.60M
Accounts payable 0.91M 0.54M 0.77M 1.22M 0.76M
Accumulated other comprehensive income -9.42M - -10.66M -12.04M -9.05M
Common stock total equity - - - 0.04M 0.04M
Retained earnings total equity - - - 126.01M 115.31M
Non currrent assets other - - -0.00M -1.51M -2.10M
Non current assets total 24.80M 26.21M 29.19M 33.95M 42.40M
Capital lease obligations 0.23M 0.28M 0.29M 0.34M 0.33M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.21M -0.59M -0.82M -0.55M
Change to liabilities - - - 0.72M 0.69M
Total cashflows from investing activities -0.37M - - -0.82M -0.55M
Total cash from financing activities -12.34M -23.84M -4.17M -5.48M -10.90M
Change to operating activities - - - 0.17M 0.59M
Net income 11.29M 13.87M 16.64M 16.47M 14.79M
Change in cash 2.78M -9.89M 17.82M 14.08M 9.38M
Begin period cash flow 82.98M 92.87M 75.05M 60.97M 51.59M
End period cash flow 85.76M 82.98M 92.87M 75.05M 60.97M
Total cash from operating activities 14.69M 14.83M 22.28M 21.15M 21.20M
Depreciation 3.01M 2.85M 6.37M 7.08M 7.28M
Other cashflows from investing activities - - - -0.01M -0.86M
Dividends paid 3.98M 4.26M 4.28M 3.16M 11.46M
Change to inventory 1.20M 0.59M -0.67M -2.35M -0.48M
Change to account receivables 0.33M -0.83M 2.27M -0.51M -1.09M
Sale purchase of stock -8.36M -19.97M -2.50M -2.50M -6.98M
Other cashflows from financing activities - 0.39M 0.12M -0.82M 13.80M
Change to netincome - - - -0.18M 0.14M
Capital expenditures 0.37M 0.23M 0.64M 0.82M 0.55M
Change receivables - - - -0.53M -1.13M
Cash flows other operating - - - -0.01M -0.08M
Exchange rate changes - - - - -0.36M
Cash and cash equivalents changes - - - 14.85M 9.38M
Change in working capital 0.32M -1.80M -0.23M -2.23M -1.01M
Stock based compensation 0.37M 0.26M 0.23M 0.18M 0.17M
Other non cash items 0.37M -0.00M -0.03M 0.04M 0.06M
Free cash flow 14.32M 14.60M 21.64M 20.33M 20.65M

Peer Comparison*

Sector: Healthcare Industry: Medical Instruments & Supplies

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
UTMD
Utah Medical Products Inc
-1.66
2.25%
71.97 22.75 13.04 6.58 1.85 3.84 10.90
ISRG
Intuitive Surgical Inc
3.70
0.84%
443.59 43.30 31.35 12.25 7.35 11.63 30.22
ESLOF
EssilorLuxottica Société anonyme
-8.90
4.32%
197.19 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA
1.64
1.66%
100.55 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company
2.32
1.08%
218.03 31.62 13.76 2.25 2.04 2.93 13.40

Profile*

Utah Medical Products Inc

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

7043 South 300 West, Midvale, UT, United States, 84047-1048

801 566 1200

140

Name Title Year Born
Mr. Kevin L. Cornwell Chairman, CEO, Pres & Sec. 1947
Mr. Brian L. Koopman Principal Financial Officer, Accounting Mang. & Controller 1970
Mark L. Fox VP of Marketing NA
Mr. Kevin L. Cornwell Chairman, CEO, President & Secretary 1947
Mr. Brian L. Koopman Principal Financial Officer, Accounting Manager & Controller 1970
Mark L. Fox Vice President of Marketing NA
Marcena H. Clawson Head of Corporate Sales NA
Marcena H. Clawson Vice President of Corporate Sales NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…